LY2979165

InvivoChem Cat #:V4849CAS #:1311385-32-6Purity >=98%

Description: LY2979165, a novel and potent mGlu2 agonist being developed as an anti-depressant drug candidate, has potential usefulness in the treatment of bipolar disorder. LY2979165 is being developed by Eli Lilly, and is currently in clinical trials.

References: http://clinicaltrials.gov/ct2/show/NCT01383967; Pharmacogenomics J. 2012 Jun; 12(3):246-54.

-20C for 3 years in powder form

Synonym: LY2979165; LY-2979165; LY 2979165.
IUPAC/Chemical Name: ammonium (1R, 2S, 4R, 5R, 6R)-4-((4H-1, 2, 4-triazol-3-yl)thio)-2-((S)-2-aminopropanamido)-2-carboxybicyclo[3.1.0]hexane-6-carboxylate hydrate
InChi Key: FICWTZOQUXUYOK-AHKKVLALSA-N
InChi Code: InChI=1S/C13H17N5O5S.H3N.H2O/c1-4(14)9(19)17-13(11(22)23)2-5(24-12-15-3-16-18-12)6-7(8(6)13)10(20)21; ; /h3-8H, 2, 14H2, 1H3, (H, 17, 19)(H, 20, 21)(H, 22, 23)(H, 15, 16, 18); 1H3; 1H2/t4-, 5+, 6-, 7-, 8-, 13-; ; /m0../s1
SMILES Code: O=C([O-])[CH]1[C]2([H])[C]1([H])[C](NC([CH](N)C)=O)(C(O)=O)C[CH]2SC3=NN=CN3.[NH4+].O